We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Usefulness of Calprotectin for Colon Adenoma Screening

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by Chul Min Park, MD, Konkuk University Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01719198
First Posted: November 1, 2012
Last Update Posted: November 14, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Chul Min Park, MD, Konkuk University Medical Center
  Purpose
The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.

Condition
Colon Adenoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Usefulness of Fecal Calprotectin for Screening Colon Adenoma in Korean Population

Resource links provided by NLM:


Further study details as provided by Chul Min Park, MD, Konkuk University Medical Center:

Primary Outcome Measures:
  • fecal calprotectin level [ Time Frame: 1 day (at the hospital visit) ]

Biospecimen Retention:   Samples Without DNA
stool specimen

Estimated Enrollment: 500
Study Start Date: October 2012
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients who visit KUH healthcare center for colonoscopy in Korea over 18 years old adult population
Criteria

Inclusion Criteria:

  • over 18 years old adult population

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01719198


Locations
Korea, Republic of
Konkuk University Medical Center Recruiting
Seoul, Korea, Republic of, 147-729
Contact: Chul Min Park, MD       i004@snu.ac.kr   
Sub-Investigator: Chul Min Park, MD         
Sponsors and Collaborators
Konkuk University Medical Center
Investigators
Principal Investigator: Yeo-Min Yun, MD, PhD Konkuk University
  More Information

Responsible Party: Chul Min Park, MD, clinical instructor, Konkuk University Medical Center
ClinicalTrials.gov Identifier: NCT01719198     History of Changes
Other Study ID Numbers: KUH1220
First Submitted: October 30, 2012
First Posted: November 1, 2012
Last Update Posted: November 14, 2012
Last Verified: November 2012

Keywords provided by Chul Min Park, MD, Konkuk University Medical Center:
adenoma
calprotectin

Additional relevant MeSH terms:
Adenoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms